Chlortetracycline hydrochloride - Generic Drug Details
✉ Email this page to a colleague
What are the generic drug sources for chlortetracycline hydrochloride and what is the scope of freedom to operate?
Chlortetracycline hydrochloride
is the generic ingredient in one branded drug marketed by Lederle and is included in one NDA. Additional information is available in the individual branded drug profile pages.There are ten drug master file entries for chlortetracycline hydrochloride.
Summary for chlortetracycline hydrochloride
US Patents: | 0 |
Tradenames: | 1 |
Applicants: | 1 |
NDAs: | 1 |
Drug Master File Entries: | 10 |
Raw Ingredient (Bulk) Api Vendors: | 133 |
Clinical Trials: | 1 |
Patent Applications: | 2,903 |
DailyMed Link: | chlortetracycline hydrochloride at DailyMed |
Recent Clinical Trials for chlortetracycline hydrochloride
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
James Graham Brown Cancer Center | Early Phase 1 |
Julio Ramirez | Early Phase 1 |
University of Louisville | Early Phase 1 |
Medical Subject Heading (MeSH) Categories for chlortetracycline hydrochloride
Anatomical Therapeutic Chemical (ATC) Classes for chlortetracycline hydrochloride
US Patents and Regulatory Information for chlortetracycline hydrochloride
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Lederle | AUREOMYCIN | chlortetracycline hydrochloride | OINTMENT;OPHTHALMIC | 050404-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |